Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ab Investor currently holds 3,509,949 shares of AGILE THERAPEUTICS INC (AGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ab Investor has been a net buyer of AGRX stock. They have purchased $22.3M and sold $4.9M worth of shares.
Ab Investor's most recent insider trade was on May 29, 2014, when they purchased 2,509,949 shares at $6.00 per share.
Ab Investor serves as Executive at AGILE THERAPEUTICS INC (AGRX). They have executed 70 insider transactions totaling $27.2M over their tenure at the company.
Ab Investor holds the position of Executive at AGILE THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Ab Investor has shown a buying trading pattern, with $22.3M in total purchases and $4.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ab Investor was on Nov 1, 2013, when they sold $100.2M worth of GWAY shares. This transaction involved 4,922,009 shares at $20.35 per share.
Ab Investor currently owns 3,509,949 shares of AGILE THERAPEUTICS INC (AGRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ab Investor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ab Investor has 70 Form 4 filings on record as an insider at AGILE THERAPEUTICS INC.
Set alerts for Ab Investor and 40,000+ other insiders.